Tuesday, 9 July 2013

Vertex Receives Australian Approval for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of ...

Older People - Yahoo! Search Results

Older People - Yahoo! Search Results

Vertex Receives Australian Approval for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of ...
http://uk.finance.yahoo.com/news/vertex-receives-australian-approval-kalydeco-212000767.html
Jul 9th 2013, 21:20

Vertex Pharmaceuticals Incorporated today announced that the Therapeutic Goods Administration of Australia has approved KALYDECO™ for people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.



You are receiving this email because you subscribed to this feed at http://blogtrottr.com

If you no longer wish to receive these emails, you can unsubscribe here:
http://blogtrottr.com/unsubscribe/7Ql/j5nDMS

No comments:

Post a Comment